A Price Disclosure in Drug Ads Misses the Point – Bloomberg

Read article - Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about President Donald Trump's proposal that drug ads on television disclose prices. Trump's proposal gives "the illusion of doing good," says Woloshin. Most people don't pay the list price for a drug, he said, "so the list price is an abstraction." Beyond that: "It could make things worse because some people assume more expensive drugs are more effective."